-+ 0.00%
-+ 0.00%
-+ 0.00%

REGENERON PHARMACEUTICALS - LIBTAYO ACHIEVES 37% REDUCTION IN RISK OF DEATH AT 44 MONTHS (HR: 0.63)

Reuters·10/25/2026 09:16:44

Please log in to view news